New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
本文は利用できません。元の情報源をご確認ください。
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.